Please be aware that all information shared here at Canada Pharmacy has been medically reviewed and fact-checked for accuracy. These verifications are made by board-certified medical professionals who have the authority required to state that information related to medical conditions, symptoms, procedures and tests, and standard treatment protocols is valid and truthful. This is based on current guidelines and consensuses shared amongst medical professionals, and in representation of the latest research.
A generic drug is a copy of the brand-name drug with the same dosage, safety, strength, quality, consumption method, performance, and intended use. Before generics become available on the market, the generic company must prove it has the same active ingredients as the brand-name drug and works in the same way and in the same amount of time in the body.
The only differences between generics and their brand-name counterparts is that generics are less expensive and may look slightly different (eg. different shape or color), as trademarks laws prevent a generic from looking exactly like the brand-name drug.
Generics are less expensive because generic manufacturers don't have to invest large sums of money to develop a drug. When the brand-name patent expires, generic companies can manufacture a copy of the brand-name and sell it at a substantial discount.
Also Known as Mezavant
IBD is a disease that affects the gastrointestinal tract, which includes the esophagus, stomach, small intestine, and large intestine. Crohn's disease typically affects both the small and large intestines, while Ulcerative Colitis affects only the large intestine.
People with IBD have chronic inflammation in either the large intestine or both the large and small intestines. During inflammation, cells become swollen and enlarged, causing pain and reducing the ability of these organs to absorb nutrients from food. LIALDA blocks certain chemicals that intestinal cells use to signal inflammation, including cyclooxygenase and prostaglandins. By inhibiting these chemicals, LIALDA reduces inflammation for people with IBD and helps to treat and prevent symptoms.
The dose of LIALDA can vary based on what is being treated. Take LIALDA exactly as prescribed by your doctor.
The usual dosage is 2.4 g to 4.8 g once daily by mouth with food. The length of treatment is typically 8 weeks to induce remission.
The active ingredient in LIALDA is mesalamine.
LIALDA generic cannot always be interchanged with other brand names since they each contain different amounts of the active ingredient and were studied under different conditions. Speak with your doctor or pharmacist before switching brands.
Tell your doctor if you have a history of cardiovascular disease. Some patients have experienced myocarditis and pericarditis while taking LIALDA.
Some patients may experience acute intolerance syndrome that is difficult to distinguish from an IBD flare-up. Symptoms include abdominal pain, cramping, diarrhea, fever, headache, and rash. If you start taking LIALDA and experience a new onset of these symptoms, tell your doctor and you may need to stop LIALDA.
Some of the most common adverse reactions that people experience when they take LIALDA include:
All of the above-listed side effects occurred in greater than 1% of people who took LIALDA during the clinical trials in which the drug gained approval. For a full list of side effects, speak with your doctor or pharmacist.